FDA Inspection 1046316 — Blood Bank Of Delmarva, a Division of New York Blood Center, Inc.
The FDA completed an inspection of Blood Bank Of Delmarva, a Division of New York Blood Center, Inc. on February 20, 2018 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 20, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Newark, DE (United States)